Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |